Get the week’s top news delivered directly to your inbox – Sign up for our newsletter
Nikkei first reported Blackstone’s planned sale of Alinamin earlier on Tuesday.
MBK aims to use its experience in consumer goods acquisitions to boost Alinamin’s value, the Nikkei reported.
Previously known as Takeda Consumer Healthcare Co, Alinamin provides over-the-counter medicines in Japan.
After Blackstone’s takeover, the company set up a unit in Taiwan and increased its overseas sales, the Nikkei reported.
Source: Reuters
Can’t stop reading? Read more
US Pipeline Operator ONEOK Inks Two Deals for $5.9 Billion
US pipeline operator ONEOK Inc. agreed to buy a Permian Basin rival and a controlling stake in...
Blackstone Is Said to Seek A$5.5 Billion Loan for AirTrunk Bid
Private equity firm Blackstone Inc. is in discussions with banks for a five-year loan of about...
Thrive Capital to lead multi-billion dollar OpenAI investment round at $100bn valuation
OpenAI, the company behind the popular AI tool ChatGPT, is in advanced talks to secure several...